Natco Set To Launch Generic Vidaza In US

Natco has announced that its Abbreviated New Drug Application for a generic version of Vidaza has received final¬† FDA approval . Natco will be launching the generic Vidaza in the US market with Breckenridge Pharmaceutical, its marketing partner. Vidaza’s branded version is produced by Celgene Corporation. The drug is a prescription anti-cancer chemotherapy drug used to treat myelodysplastic syndrome, or MDS. Vidaza has annual sales of $188 million.

Read the source article at ET Healthworld